Sentinel lymph node biopsy for in situ melanoma is unlikely in Australia

Response to: ‘Sentinel lymph node biopsy for in situ melanoma is unlikely in Australia’ by Morton and Thompson

“…We thank Drs Morton and Thompson1 for their comments on our indicator for low-value sentinel lymph node biopsy (SLNB). They provide a plausible explanation for our finding that SLNB appears to be used for melanoma in situ in public hospitals in New South Wales (NSW).…”